Istituto Rudy Lanza - Catalogo bibliografico delle tesi

Ritengo di non essere l’unico a pensare che non esista altra nazione al mondo che abbia una storia nella medicina tradizionale così datata nella notte dei tempi come la Cina.

Milioni di persone già praticavano la medicina naturale ancor prima che Ippocrate scrivesse il suo trattato, Egizi a parte, di cui però abbiamo poca documentazione.

Probabilmente a qualcuno ciò potrà sembrare semplicemente uno dei tanti dati folkloristici che accompagnano la storia cinese, non soltanto quella medica.

Se per certi versi posso essere d’accordo, alcuni aspetti sono in effetti un po’ sconcertanti per il nostro modus vivendi, non lo sono certo per quanto riguarda la storia che accompagna alcuni rimedi naturali, tra i quali a mio avviso, primeggia il fungo Reishi.

AHCC

1. Nair MP, et al."Effect of neuropeptide Y on natural killer activity of normal human lymphocytes," Brain Behav Immun Mar;7(1): 70-8, 1993.
2. Whiteside TL, Herberman RB, "The association of abnormalities in NK cell numbers or functions with a broad spectrum of human diseases has been more clearly defined in recent years" Clin Diagn Lab Immunol Mar;1(2):125-33, 1994.
3. Raison CL, Miller AH., "The neuroimmunology of stress and depression," Semin Clin NeuropsychiatryÊ 2001 Oct;6(4):277-94
4. Glaser R, Kiecolt-Glaser JK., "Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome," Am J Med 1998 Sep 28;105(3A):35S-42S
5. Whiteside TL, Friberg D., "Natural killer cells and natural killer cell activity in chronic fatigue syndrome," Am J Med 1998 Sep 28;105(3A):27S-34S
6. Matsui Y, et al., "Preventive Effect of Active Hexose Correlated Compound (AHCC) on the Recurrence of Postoperative Hepatocellular Carcinoma Patients," XXXIIIrd Congress of the European Society for Surgical Research, 1998 p74
7. Wang S,et al. "AHCC on Immobilization Stress in the Rat: Beneficial Effects of Active Hexose Correlated Compound" Dokkyo Journal of Medical Sciences p. 559 28(1): 559 ~ 565, 2001

Ganoderma Lucidum

• Wang et al. "Alteration of pulse in human subjects by three Chinese herbs", Biosciences Information Service, Philadelphia, Pa., see entire article specially the abstract (1994).*
• Yun Taik-Koo, Updated from Asia: Asian studies on cancer chemoprevention, Biosciences Information Service, Philadelphia, PA, Abstract (1999).
• O.A. Bocharova et al, "Testing plant-based drugs for prevention and nontoxic theraphy of cancer diseases on experimental models,", Biosciences Information Service, Philadelphia, PA, Abstract, and Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, No. 2, p. 52-55, (1994).
• Zee-Cheng et al, "Ten Significant Tonic Decoction, SQT: A potent Chinese biological response modifier in cancer immunotheraphy, potentiation and detoxificatin of anticancer drugs.", Biosciences Information Service, Philadelphia, P., Abstract (1992).
• Wang Wei Kung et al, "Alteration of pulse in human subjects by three Chinese herbs", Biosciences Information Service, Philadelphia, PA, Abstract (1994).
• Oh William K et al, "Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer", Biosciences Information Service, Philadelphia, PA, abstract (2001).
• Yamamoto et al., "Immunopotentiating Activity of the Water-soluble Lignin Rich Fraction Prepared from LEM--The Extract of the Solid Culture Medium of Lentinus edodes Mycelia" Biosci, Biotech, Biochem., 61 (11), pp 1909-1912, 1997.
• Morinaga et al., "An in vivo Study of Hepatic and Splenic Interleukin-1.beta. mRNA Expression Following Oral PSK or LEM Administration" Jpn. J. Cancer Res. 85, pp 1298-1303, Dec. 1994.
• Kano et al., "Augmentation of the antitumor effect of adoptive immunotherapy by in vivo sensitization of EL-4 lymphoma and pre-treatment with sizofiran" Biotherapy, 11, pp 1-6, 1998.
• M. Ghoneum. NK Immunomodulation by active Hemicellulose Compound in 17 Cancer Patients. 1994. Natural Immunity, 13(4) p. 228.
• Singleton et al., 1991. Dictionary of Microbiology and Molecular Biology, John Wiley and sons, p., 460.
• Ikekawa, et al., Chem. Pharm. Bull, vol. 40, No. 7, pp. 1954-1957, XP-001146586, "Antitumor Activity of Hypsizigus Marmoreus. I. Antitumor Activity of Extracts and Polysaccharides", 1995.
• H. Saitoh, et al., Pharmaceutical Society of Japan, vol. 117, No. 12, pp. 1006-1010, XP-009008577, "Antitumor Activity of Hypsizigus Marmoreus. II.
• Preventive Effect Against Lung Metastasis of Lewis Lung Carcinoma", 1997.
• K. Tsuchida, et al., The Journal of Biological Chemistry, vol. 270, No. 4, pp. 1481-1484, XP-001146585,
• "Isolation of a Novel Collagen-Binding Protein from the Mushroom, Hypsizigus Marmoreus, Which Inhibits The Lewis Lung Carcinoma Cell Adhesion to Type IV Collagen", 1995.
• T. Matsuzawa, et al., Yakugaku Zasshi, vol. 118, No. 10, pp. 476-481, XP-009008578, "Studies on Antioxidant Effects of Hypsizigus Marmoreus. II.
• " Effects of Hypsizigus Marmoreus For Antioxidant Activities of Tumor-Bearing Mice, Oct. 1998.
• Akihisa T, et al., "Triterpene Alcohols From The Flowers Of Compositae And Their Anti-Inflammatory Effects," Phytochemistry Dec. 1996;43(6):1255-1260.
• Bao X, et al., "Structural And Immunological Studies Of A Major Polysaccharide From Spores Of Ganoderma Lucidum (Fr.) Karst," Carbohydr Res May 8, 2001:332(1):67-74.
• Cassidy, C.M., "Chinese Medicine Users In The United States Part I: Utilization, Satisfcation, Medical Plurality," J. Alt. Comp. Med. 1998 4:17-27.
• Cassidy, C.M., "Chinese Medicine Users In The United States Part II: Preferred Aspects Of Care," J. Alt. Comp. Med. 1998 4:189-202.
• Cheung W.M., et al., "Ganoderma Extract Activates MAP Kinases And Induces The Neuronal Differentiation Of Rat Pheochromocytoma PC12 Cells," FEBS Lett Dec. 15, 2000:486(3):291-296.
• Choate, C., "Modern Medicine and Traditional Chinese Medicine; Diabetes Mellitus, Part Three," J. Chinese Med., No. 60, May 1999.
• Chu, D.T., et al., "Fractionated Extract of Astragalus membranaceus, a Chinese Medicinal Herb, Potentiates LAK Cell Cytotoxicity Generated By A Low Dose Of Recombinant Interleukin-2," J. Clin. Lab Immunol. 26, 183-187 (1988).
• Chu, D.T., et al., "Immunotherapy with Chinese Medicinal Herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo," J. Clin. Lab. Immunol 1988 25:125-129.
• De la Taille A, et al., "Role Of Herbal Compounds (PC-SPES) In Hormone-Refractory Prostate Cancer: Two Case Reports," J Altern. Complement Med Oct. 2000;6(5):449-451).
• Eisenberg, D.M., et al. "Trends In Alternative Medicine Use In The United States, 1990-1997: Results Of A Follow-Up National Survey," JAMA, J. Am. Med. Assoc. 1988 280:1569-1575.
• Eisenberg, D.M., et al., "Unconventional Medicine In The United States: Prevalence, Costs, And Patterns Of Use," N. Engl. J. Med. 1993 328:246-252.
• Hu CQ, et al., "Anti-AIDS Agents, 10. Acacetin-7-O-beta-D-galactopyranoside, An Anti-HIV Principle From Chrysanthemum Morifolium And A Structure-Activity Correlation With Some Related Flavonoids," J. Nat. Prod. Jan. 1994 57(1):42-51.
• Hu S., et al., "Influence Of Medicinal Herbs On Phagocytosis By Bovine Neutrophils," Zentralbl Veterinarmed A Oct. 1992 39(8):593-599.
• Jiezhong, X., "Senile Dementia; Experience in Treatment According to Differentiation of Patterns," J. Chinese Med., No. 53, Jan. 1997.
• Jin, R. and Kurashige, S., "Effects Of Chinese Herbs On Macrophage Functions In N-Butyl-N-Butanolnitrosoamine Treated Mice," Immunopharmacol Immunotoxicol 1996 18:105-114.
• Kurashige, S., et al., "Effects Of Astragali Radix Extract On Carcinogenesis, Cytokine Production, And Cytotoxicity In Mice Treated With A Carcinogen, N-Butyl-N'-Butanolnitrosoamine," Cancer Invest. 1999 17:30-35.
• Lee J.M., et al., "Inhibition Of Lipid Peroxidation And Oxidative DNA Damage By Ganoderma Lucidum," Phytother Res May 15, 2001(3):245-249.
• MacLennan, A.H., et al., "Prevalence And Cost Of Alternative Medicine In Australia," Lancet 1996 347:569-573.
• Matsuura K, et al., "Role Of B-Lymphocytes In The Immunopharmacological Effects Of A Traditional Chinese Medicine, Xiao-Chai-Hu-Tang (Shosaiko-to)," Int. J. Immunopharmacol. 1993 15:237-243.
• Rittenhouse, J.R., et al., "Chinese Medicinal Herbs Reverse Macrophage Suppression Induced By Urological Tumors," J. Urol. 1991 146:486-490.
• Sun, Y., et al., "Immune Restoration And/Or Augmentation Of Local Graft Versus Host Reaction By Traditional Chinese Medicinal Herbs," Cancer Invest. 1983 52:70-73.
• Tomlinson, B., et al., "Toxicity Of Complementary Therapies: An Eastern Perspective," Journal Of Clinical Pharmacology 2000 40:451-456.
• Ukiya M., et al., "Constituents Of Compositae Plants. 2. Triterpene Diols, Triols, And Their 3-O-Fatty Acid Esters From Edible Chrysanthemum Flower Extract And Their Anti-Inflammatory Effects," J Agric Food Chem Jul. 2001 49(7):3187-3197.
• Wang H.K., et al., "Recent Advances In The Discovery And Development Of Flavonoids And Their Analogues As Antitumor And Anti-HIV Agents," Adv Exp Med Biol 1998 439:191-225.
• Yamada H, et al., "Mitogenic And Complement Activating Activities Of The Herbal Components Of Juzen-Taiho-To," Planta Med. 1992 58:166-170.
• Yoshida, Y., et al., "Immunomodulating Activity Of Chinese Medicinal Herbs And Oldenlandia Diffusa In Particular," Int. J. Immunopharmacol. 1997 19:359-370.
• Zhang L., et al., "Solution Properties Of Antitumor Sulfated Derivative Of Alpha-(1.fwdarw.3)-D-Glucan From Ganoderma Lucidum," Biosci Biotechnol Biochem Oct. 2000 64(10):2172-2178.